Know Cancer

or
forgot password


N/A
N/A
N/A
Open (Enrolling)
Both
Orbial Mass Lesion

Thank you

Trial Information


Inclusion Criteria:



- unresectable mass lesions with diffuse involvement of the orbit or the tumors with
infiltrative growth and indistinct borders which needed to have morphologic
verification

Exclusion Criteria:

- An anti-coagulant therapy at the time of biopsy,

- bleeding diathesis,

- suspected hypervascular lesions,

- orbital roof destruction with a tumor,

- apical location of the tumor

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

true identification of an orbital tumor with a core needle biopsy

Outcome Time Frame:

five years

Safety Issue:

Yes

Authority:

Russia: Ministry of Health of the Russian Federation

Study ID:

core biopsy of orbital tumors

NCT ID:

NCT01772355

Start Date:

October 2008

Completion Date:

June 2014

Related Keywords:

  • Orbial Mass Lesion
  • orbit; tumor; core biopsy

Name

Location